A major European study has found that offering routine prostate cancer screening to all men over 50 could save thousands of lives. The 23-year trial of 162,000 men across eight countries showed that regular prostate-specific antigen (PSA) blood tests reduced prostate cancer deaths by 13%, matching the life-saving impact of breast and bowel cancer screening. The findings strengthen calls for the UK to introduce a national prostate screening programme. Experts say earlier detection allows curative treatment before symptoms appear, though some warn of overdiagnosis and overtreatment of harmless tumours. Advances such as MRI scanning and precision surgery now reduce these risks. Prostate cancer is the UK’s most common cancer, causing more than 12,000 deaths a year. Health officials will review the results next month, and advocates say the evidence is now overwhelming. Campaigners urge government action to protect men’s health, noting that high-risk groups such as black men and those with family histories remain especially vulnerable.